文献速递运动医学关节外科

前列腺素E2改善衰老加重的肩袖肌肉萎缩

PGE2 Ameliorates Aging-Aggravated Rotator Cuff Muscle Atrophy.
PubMed 文献 · J Bone Joint Surg Am · 2025-06-06

研究在自然衰老和肩袖撕裂(RCT)小鼠模型中观察前列腺素E2(PGE2)对肌肉结构和线粒体功能的影响,使用SW033291抑制PGE2降解。结果显示衰老和撕裂共同加重肌肉萎缩和脂肪浸润,SW033291提高PGE2水平并逆转肌肉萎缩、减轻线粒体功能障碍,支持升高PGE2改善肌肉健康的假设。

要点

  • 衰老和肩袖撕裂共同加重小鼠肩袖肌肉萎缩和脂肪浸润。
  • 衰老撕裂组肌肉质量从45.45 ± 4.04降至25.18 ± 1.82 mg(p < 0.001)。
  • SW033291提高PGE2水平,逆转两模型中的肌肉萎缩和线粒体功能障碍。

核心结论

  • 研究结果支持升高PGE2水平可通过逆转线粒体功能障碍改善肌肉健康的假设,为对抗肌肉减少症和增强肩袖修复提供策略。

研究设计与样本

  • 共使用20只年轻(5至6月龄)和100只衰老(18至20月龄)雌性C57BL/6J小鼠,分为两组:第一组含年轻、衰老、衰老+SW033291亚组用于研究肌肉减少症;第二组含撕裂、撕裂+修复、撕裂+修复+SW033291亚组用于检查肩袖撕裂后的结果。

主要发现

  • 在自然衰老和肩袖撕裂情况下均观察到肩袖肌肉退变,两者共同加重肌肉萎缩和脂肪浸润。
  • 衰老撕裂组肌肉质量从均值±标准差45.45 ± 4.04降至25.18 ± 1.82 mg(p < 0.001),纤维横截面积(CSA)从1,697.3 ± 108.4降至1,263.0 ± 56.8 μm²(p < 0.001)。
  • 衰老撕裂组15-前列腺素脱氢酶(15-PGDH)活性增加,PGE2水平从2.897 ± 0.177降至1.873 ± 0.179 ng/g肌肉(p < 0.001)。
  • SW033291治疗提高PGE2水平,在两种条件下肌肉质量为33.50 ± 3.05 mg、CSA为1,423.6 ± 81.3 μm²,逆转肌肉萎缩并减轻线粒体功能障碍。

临床怎么用

  • 作者认为,增强PGE2水平可减轻自然衰老和肩袖撕裂小鼠模型中的肩袖肌肉退变和肌肉线粒体功能障碍。
  • 作者指出,该发现证明应用15-PGDH抑制剂的疗效,并提示一种可能的新治疗方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aging-related escalation of muscle degeneration impacts the structure and function of rotator cuff muscles, contributing to spontaneous and tear-induced muscle atrophy. This study investigated how prostaglandin E2 (PGE2), a regulator of muscle regeneration, influences muscular structure and mitochondrial function in aged mice by using SW033291 to inhibit PGE2 degradation, revealing potential therapeutic pathways for mitigating rotator cuff muscle deterioration. METHODS: A total of 20 young (5 to 6-month-old) and 100 aged (18 to 20-month-old) female C57BL/6J mice were divided into 2 groups: the first group included young, aged, and aged+SW033291 subgroups and was used to study sarcopenia, and the second group consisted of tear, tear+repair, and tear+repair+SW033291 subgroups and was used to examine the outcomes following a rotator cuff tear (RCT). Tissue staining, muscle mass assessments, functional assays, and mitochondrial function tests were performed. RESULTS: Rotator cuff muscle degeneration was observed in the setting of natural aging and in the setting of an RCT. These conditions together worsened muscle atrophy and fatty infiltration into the muscle, with the aged tear group demonstrating a decrease in muscle mass from a mean and standard deviation of 45.45 ± 4.04 to 25.18 ± 1.82 mg (p < 0.001) and a reduction in fiber cross-sectional area (CSA) from 1,697.3 ± 108.4 to 1,263.0 ± 56.8 μm 2 (p < 0.001). This was linked to increased 15-prostaglandin dehydrogenase (15-PGDH) activity and a reduction in PGE2 levels in the aged tear group (from 2.897 ± 0.177 to 1.873 ± 0.179 ng/g muscle; p < 0.001). SW033291 treatment increased the level of PGE2, reversing muscle atrophy by mitigating mitochondrial dysfunction in both models, as demonstrated by a muscle mass of 33.50 ± 3.05 mg and a CSA of 1,423.6 ± 81.3 μm 2 in the presence of both conditions. CONCLUSIONS: These findings support the hypothesis that elevated PGE2 levels can improve muscle health by reversing mitochondrial dysfunction, offering a strategy to combat sarcopenia and to enhance rotator cuff repair. CLINICAL RELEVANCE: Large or massive RCTs are associated with muscle atrophy, a higher retear rate, and suboptimal surgical outcomes, especially in elderly patients. This study showed that the occurrence of rotator cuff muscle degeneration and muscular mitochondrial dysfunction in both the natural aging and RCT mouse models was mitigated by enhanced PGE2 levels. This finding demonstrates the efficacy of the application of a 15-PGDH inhibitor and suggests a possible new therapeutic approach.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Shu L, Wang X, Wang H, et al. PGE2 Ameliorates Aging-Aggravated Rotator Cuff Muscle Atrophy. J Bone Joint Surg Am. 2025. PMID: 40479501. doi:10.2106/JBJS.24.00866

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。